Connection

Silvio Danese to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Silvio Danese has written about Protein Kinase Inhibitors.
Silvio Danese
Connection Strength
0.612
Protein Kinase Inhibitors
  1. Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis. Inflamm Bowel Dis. 2018 09 15; 24(10):2106-2112.
    View in: PubMed
    Score: 0.362
  2. The Expanding Therapeutic Armamentarium for Inflammatory Bowel Disease: How to Choose the Right Drug[s] for Our Patients? J Crohns Colitis. 2018 Jan 05; 12(1):105-119.
    View in: PubMed
    Score: 0.086
  3. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2017 05 04; 376(18):1723-1736.
    View in: PubMed
    Score: 0.082
  4. JAK inhibition in inflammatory bowel disease. Expert Rev Clin Immunol. 2017 07; 13(7):693-703.
    View in: PubMed
    Score: 0.081
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.